Viviane Nunes | Biology | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Viviane Nunes
Universität Tübingen, Germany

Viviane Nunes
Affiliation Universität Tübingen
Country Germany
Scopus ID 57208001324
Documents 6
Citations 25
h-index 3
Subject Area Biology
Event Scientific World Research Awards

Viviane Nunes is affiliated with Universität Tübingen and contributes to biological research through studies involving taxonomy, biodiversity, phylogeography, and evolutionary investigations. Her scholarly profile demonstrates engagement with biological systematics and species-level research, supported by publications indexed in international databases and recognized through citation activity.[1]

Abstract

This article presents an overview of Viviane Nunes and her eligibility for the Innovative Research Award. Associated with Universität Tübingen, her research activities focus on biological diversity, systematics, phylogeography, and integrative taxonomy. Available Scopus metrics indicate six indexed publications, twenty-five citations, and an h-index of three. Her scientific contributions support the understanding of species classification and evolutionary relationships, particularly through studies involving European fireflies and biodiversity assessment. These achievements reflect active participation in contemporary biological research and demonstrate scholarly engagement with topics relevant to taxonomy, conservation biology, and evolutionary science.[1]

Keywords

Biology, Biodiversity, Taxonomy, Phylogeography, Evolutionary Science, Conservation Research.

Introduction

Biological sciences contribute significantly to understanding biodiversity, species evolution, and ecological relationships. Researchers in this field provide valuable evidence supporting conservation and scientific classification efforts.[2]

Research Profile

The research profile of Viviane Nunes reflects participation in biological systematics and biodiversity studies, supported by internationally indexed publications and collaborative research activities.[1]

Research Contributions

Her contributions include investigations into species diversity, phylogeography, and integrative taxonomy, supporting scientific understanding of evolutionary patterns and biological classification.[2]

Publications

A recent publication examines the systematics, phylogeography, and integrative taxonomy of European Luciola fireflies, highlighting contemporary approaches to biodiversity research.[3]

Research Impact

Citation records and scholarly output demonstrate academic visibility and engagement within the biological sciences, reflecting the dissemination of research findings to broader scientific communities.[1]

Award Suitability

The combination of scientific publications, citation performance, and contributions to biodiversity research supports consideration for recognition through the Scientific World Research Awards.[2]

Conclusion

Viviane Nunes has contributed to biological research through studies in taxonomy and biodiversity. Her scholarly work supports continued advancement in understanding species diversity and evolutionary relationships.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Viviane Nunes, Author ID 57208001324. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57208001324
  2. Eberhard Karls Universität Tübingen. (n.d.). Research activities in biology and biodiversity sciences.
    https://uni-tuebingen.de/en/
  3. Nunes, V. C. S., et al. (2026). Systematics, phylogeography and integrative taxonomy of European Luciola fireflies.
    https://doi.org/10.1080/14772000.2026.2632789

Sihe Zhang | Medicine | Distinguished Scientist Award

Published on by Scientific World Research Awards

Distinguished Scientist Award

Sihe Zhang
Nankai University, China

Sihe Zhang
Affiliation Nankai University
Country China
Scopus ID 7409373738
Documents 55
Citations 1,269
h-index 16
Subject Area Medicine
Event Scientific World Research Awards
ORCID 0000-0002-8923-1993

The Distinguished Scientist Award recognizes the scholarly achievements of Sihe Zhang, Professor and Director at Nankai University School of Medicine. His research focuses on cancer biology, drug delivery systems, endocytosis, extracellular vesicles, antibody therapeutics, and translational medicine. Through sustained contributions to hepatocellular carcinoma and ovarian cancer research, he has developed innovative approaches that connect molecular mechanisms with therapeutic applications.[1]

Abstract

Sihe Zhang is a biomedical researcher whose work spans cancer biology, antibody engineering, cellular uptake mechanisms, extracellular vesicle biology, and targeted therapeutic delivery. His investigations have contributed to understanding macropinocytosis, endocytic recycling, tumor progression, and resistance mechanisms in hepatocellular and ovarian cancers. He has also participated in the development of innovative antibody-based therapies and nanomedicine strategies aimed at improving treatment specificity and efficacy. His publication portfolio demonstrates a sustained commitment to translational medical research and interdisciplinary collaboration, supporting advancements in cancer diagnosis, drug delivery, and precision medicine.[1][2]

Keywords

Cancer Biology; Drug Delivery; Endocytosis; Extracellular Vesicles; Antibody Therapeutics; Hepatocellular Carcinoma; Ovarian Cancer; Nanomedicine.

Introduction

Professor Zhang has held academic positions at Nankai University and previously at the Fourth Military Medical University. His career reflects long-term engagement with molecular medicine and cell biology, emphasizing mechanisms that influence cancer progression and treatment response.[1]

Research Profile

His research profile combines laboratory discovery with translational applications. Major themes include cellular trafficking, therapeutic antibodies, tumor microenvironment studies, and targeted delivery platforms designed to improve treatment outcomes in oncology.[1]

Research Contributions

Notable contributions include investigations into CD147-mediated signaling, extracellular vesicle uptake, macropinocytosis-driven drug resistance, and antibody-based cancer therapies. These studies have expanded understanding of tumor biology and therapeutic targeting strategies.[2][3]

Publications

His scholarly record includes 55 indexed publications. Representative works address hepatocellular carcinoma resistance mechanisms, extracellular vesicle biology, peptide delivery systems, anti-CD147 therapeutics, and nanobiotechnology-based treatment approaches.[2][4]

Research Impact

With 1,269 citations and an h-index of 16, his research has influenced studies in cancer therapeutics, molecular oncology, and biomedical engineering. The impact of his work is reflected through citations, collaborations, and peer-review activities across leading journals.[1]

Award Suitability

The breadth of Professor Zhang’s contributions, combined with sustained publication output and translational relevance, aligns with the objectives of the Scientific World Research Awards. His work demonstrates scientific rigor and practical relevance in medicine.[1]

Conclusion

Sihe Zhang has established a recognized research portfolio in cancer biology and therapeutic innovation. His scholarly achievements and ongoing contributions support recognition through the Distinguished Scientist Award.[1]

References

  1. ORCID. (2026). Sihe Zhang (0000-0002-8923-1993) Research Profile.https://orcid.org/0000-0002-8923-1993
  2. Qian, L., et al. (2025). The uptake of extracellular vesicles: Research progress in cancer drug resistance and beyond. Drug Resistance Updates.https://doi.org/10.1016/j.drup.2025.101209
  3. Qi, F.Z., et al. (2024). Hypoxia-activated ADCC-enhanced humanized anti-CD147 antibody. MedComm.https://doi.org/10.1002/mco2.512
  4. Sun, Z., et al. (2023). Cell-Penetrating Peptide-Based Delivery of Macromolecular Drugs. Biomedicines.https://doi.org/10.3390/biomedicines11071971
  5. Wang, B., et al. (2024). Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302. International Journal of Biological Sciences.https://doi.org/10.7150/ijbs.92211

Asterios Deligiannis | Medicine | Best Innovation Award

Published on by Scientific World Research Awards

Best Innovation Award

Asterios Deligiannis

Researcher Information
Affiliation Aristotle University of Thessaloniki
Country Greece
Scopus ID 7003501457
Documents 127
Citations 5,944
h-index 28
Subject Area Chemistry
Event Scientific World Research Awards
ORCID 0000-0001-7765-1897

Asterios Deligiannis is an academic affiliated with Aristotle University of Thessaloniki, Greece. His scholarly record demonstrates extensive research productivity, interdisciplinary collaboration, and sustained scientific contribution. According to available research metrics, he has produced 127 indexed publications, received 5,944 citations, and achieved an h-index of 28, reflecting broad academic visibility and influence across multiple research domains.[1][2]

Abstract

This article presents an overview of the academic achievements of Asterios Deligiannis. His research portfolio encompasses a substantial body of scholarly work, international collaborations, and contributions to scientific knowledge. Available publication metrics indicate 127 indexed documents, 5,944 citations, and an h-index of 28, reflecting sustained research productivity and scholarly influence.[1] His academic activities include participation in international research initiatives, professional organizations, and peer-reviewed publications. These accomplishments demonstrate innovation, research leadership, and measurable scientific impact, supporting consideration for recognition through the Best Innovation Award within an international academic framework.[2]

Keywords

Innovation, Chemistry, Scientific Research, Academic Impact, Research Excellence, Scholarly Contributions.

Introduction

Research innovation is commonly assessed through scientific productivity, influence, and contributions to knowledge development. Academic recognition programs frequently consider publication records, citation performance, and interdisciplinary engagement when evaluating researchers for distinguished awards.[1]

Research Profile

Deligiannis is affiliated with Aristotle University of Thessaloniki and maintains an active ORCID record. His professional activities include academic leadership, international memberships, and participation in collaborative research programs.[2]

Research Contributions

His scholarly contributions span cardiovascular health, exercise-related investigations, rehabilitation studies, and interdisciplinary scientific research. Numerous peer-reviewed publications demonstrate long-term engagement in advancing evidence-based knowledge and innovation.[3]

Publications

The researcher has authored 127 indexed publications and contributed to a broad collection of scientific articles published in international journals. His publication record reflects sustained scholarly activity and extensive collaboration across research communities.[1]

Research Impact

Research influence is demonstrated through 5,944 citations and an h-index of 28. These indicators suggest significant academic visibility and continuing relevance of his publications within scientific literature and research networks.[1]

Award Suitability

The combination of research productivity, scholarly impact, international engagement, and documented scientific contributions supports consideration for the Best Innovation Award. His profile reflects characteristics commonly associated with academic distinction and innovation-oriented recognition.[1]

Conclusion

Asterios Deligiannis has established a substantial academic record characterized by impactful publications, collaborative research activities, and measurable scholarly influence. These achievements provide a strong foundation for recognition within international research award programs.

References

  1. Elsevier. (n.d.). Scopus Author Details: Asterios Deligiannis, Author ID 7003501457. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=7003501457

  2. ORCID. (2026). Asterios Deligiannis ORCID Record.

    https://orcid.org/0000-0001-7765-1897

  3. Deligiannis, A., et al. (2025). Investigating the Role of Exercise in Improving Bone Health Among Elderly Women with Osteopenia.

    https://doi.org/10.3390/jfmk10040451

  4. Deligiannis, A., et al. (2025). Advanced Stress Echocardiography with Cardiopulmonary Exercise Testing After Myocardial Infarction.

    https://doi.org/10.3390/jfmk10040393

  5. Scientific World Research Awards. (n.d.). Official Award Information Portal.

    https://scientificworld.net/

Yoshiya Tanaka | Medicine | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Yoshiya Tanaka

Yoshiya Tanaka
Affiliation Hospital of University of Occupational and Environmental Health
Country Japan
Scopus ID 56328279400
Documents 1,326
Citations 50,831
h-index 99
Subject Area Medicine
Event Scientific World Research Awards

Yoshiya Tanaka, Hospital of University of Occupational and Environmental Health, Japan, is recognized for substantial contributions to rheumatology, immunology, and autoimmune disease research. His scholarly output, clinical investigations, and leadership in international collaborations have supported advancements in evidence-based medical practice and therapeutic development.[1]

Abstract

The Innovative Research Award recognizes researchers whose work demonstrates sustained scientific excellence and measurable impact. Yoshiya Tanaka has contributed extensively to rheumatology and clinical immunology through studies on autoimmune diseases, inflammatory mechanisms, biologic therapies, and targeted treatments. His research has informed clinical guidelines, improved disease classification systems, and supported the development of therapeutic strategies for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and IgG4-related disease. With a substantial publication record and broad international collaboration, his work has influenced both academic research and patient care, reflecting the objectives of the Scientific World Research Awards.[1][2]

Keywords

Rheumatology, Clinical Immunology, Autoimmune Diseases, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Biologic Therapy, Translational Medicine.

Introduction

Modern rheumatology depends on interdisciplinary research linking immunology, molecular biology, and clinical practice. Yoshiya Tanaka has participated in investigations that enhanced understanding of inflammatory pathways and treatment approaches for immune-mediated diseases.[3]

Research Profile

As Professor and Chairman in rheumatology and clinical immunology, Tanaka has developed a research portfolio focused on disease mechanisms, therapeutic innovation, and clinical trial leadership. His scholarly record reflects long-term engagement with translational medicine and global collaboration.[1]

Research Contributions

Key contributions include studies supporting lupus classification criteria, IgG4-related disease frameworks, Janus kinase inhibitor development, and biologic treatment evaluation. These efforts have contributed to improved disease assessment and therapeutic decision-making.[2][4]

Publications

  • 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
  • Trial of Anifrolumab in Active Systemic Lupus Erythematosus.
  • Janus Kinase-Targeting Therapies in Rheumatology.

Research Impact

The researcher’s publications have received extensive citations, demonstrating influence across clinical medicine and immunology. Findings from collaborative studies have informed guidelines, therapeutic development, and evidence-based healthcare practices internationally.[1][5]

Award Suitability

The breadth of scientific output, citation performance, clinical relevance, and leadership in collaborative research aligns with the objectives of the Innovative Research Award. His contributions demonstrate sustained scholarly influence and practical significance in medicine.

Conclusion

Yoshiya Tanaka’s career reflects a consistent commitment to advancing knowledge in rheumatology and autoimmune disease research. His achievements support recognition within international scientific award programs and academic communities.

References

  1. Elsevier. (n.d.). Scopus author details: Yoshiya Tanaka, Author ID 56328279400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56328279400
  2. Aringer, M., et al. (2019). 2019 EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus.
    DOI: https://doi.org/10.1002/art.40930
  3. Tanaka, Y., Adams, D.H., & Shaw, S. (1993). T-cell Adhesion Induced by Proteoglycan-Immobilized Cytokine MIP-1β.
    DOI: https://doi.org/10.1038/361079a0
  4. Tanaka, Y., Luo, Y., O’Shea, J.J., & Nakayamada, S. (2022). Janus Kinase-Targeting Therapies in Rheumatology.
    DOI: https://doi.org/10.1038/s41584-021-00726-8
  5. Google Scholar. (2026). Yoshiya Tanaka Citation Profile.
    https://scholar.google.com/citations?user=t_hAg7QAAAAJ&hl=en

Victoria Bunik | Biology | Innovative Research Award

Published on by Scientific World Research Awards

Innovative Research Award

Victoria Bunik

Victoria Bunik
Affiliation Moscow State University
Country Russia
Scopus ID 7003933084
Documents 130
Citations 3,738
h-index 32
Subject Area Biology
Event Scientific World Research Awards
ORCID 0000-0002-2552-8560

Victoria Bunik is a researcher associated with biological sciences and neurochemical research at Moscow State University. Her scholarly work includes studies on metabolic regulation, mitochondrial biochemistry, neurodegenerative mechanisms, vitamin-dependent biochemical pathways, and molecular neurobiology.[1] Her publications demonstrate sustained contributions to biochemical and neurological research through interdisciplinary scientific investigations involving enzymatic regulation, metabolic disorders, and molecular therapeutic approaches.

Abstract

Victoria Bunik has contributed extensively to biological and neurochemical sciences through research involving mitochondrial metabolism, enzymatic regulation, vitamin-dependent biochemical processes, and neurological disorders. Her publications examine molecular mechanisms associated with epilepsy, neurodegeneration, metabolic adaptation, and cellular signaling pathways.[2] Her interdisciplinary studies integrate biochemical analysis with molecular biology approaches to investigate metabolic homeostasis and neurological function. The research output demonstrates sustained academic engagement in neurochemistry and molecular biology, contributing to scientific understanding of metabolic regulation and potential therapeutic pathways in complex neurological and biochemical disorders.

Keywords

Biology, Neurochemistry, Molecular Biology, Metabolic Regulation, Mitochondrial Biochemistry, Neurological Disorders

Introduction

Modern biological research increasingly focuses on understanding metabolic regulation and molecular signaling in neurological systems. Scientific investigations involving mitochondrial function and vitamin-dependent enzymatic activity are important for advancing biomedical knowledge.[3] Victoria Bunik’s work contributes to this area through studies examining neurochemical and biochemical pathways.

Research Profile

Her research profile reflects extensive publication activity in biology and neurochemistry with an h-index of 32 and more than 3,700 citations. Her academic contributions include journal articles and collaborative studies involving molecular biology, epilepsy research, mitochondrial metabolism, and vitamin-related biochemical regulation.[1]

Research Contributions

Victoria Bunik has contributed to studies involving pyruvate dehydrogenase regulation, protein acylation, epilepsy-related metabolism, and neurochemical responses to vitamins B1 and B6.[4] Her work also includes investigations into glutamate dehydrogenase activity and biochemical markers associated with neurological conditions.

Publications

  • “Pentylenetetrazole-Induced Seizures Are Increased after Kindling.”
  • “Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase.”
  • “Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.”

Research Impact

The research conducted by Victoria Bunik contributes to scientific understanding of neurochemical regulation and metabolic adaptation in neurological systems. Her work has relevance for molecular medicine, neurodegenerative disease research, epilepsy studies, and biochemical therapeutic investigations.[5]

Award Suitability

Victoria Bunik’s sustained publication record, interdisciplinary biological research, and scholarly impact demonstrate suitability for recognition through the Innovative Research Award. Her scientific contributions support continued advancement in neurochemistry, metabolic biology, and molecular biomedical sciences.

Conclusion

The academic work of Victoria Bunik reflects consistent engagement in biological and neurochemical sciences through studies focused on metabolic regulation, molecular signaling, and neurological processes. Her research contributions continue to support scientific progress in molecular biology and neurochemistry.

References

  1. Elsevier. (n.d.). Scopus author details: Victoria Bunik, Author ID 7003 933084. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003933084
  2. Bunik, V. et al. (2023). Pentylenetetrazole-Induced Seizures Are Increased after Kindling. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms241512405
  3. ORCID. (2026). Victoria Bunik Research Record.
    https://orcid.org/0000-0002-2552-8560
  4. Bunik, V. et al. (2022). Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase. Journal of Neurochemistry.
    https://doi.org/10.1111/jnc.15576
  5. Bunik, V. et al. (2010). Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.
    https://doi.org/10.4061/2010/749061

Xu-hua Wang | Biotechnology | Research Excellence Award

Published on by Scientific World Research Awards

Assoc. Prof. Dr. Xu-hua Wang | Biotechnology | Research Excellence Award

Zhejiang University, China

Dr. Xuhua Wang is an accomplished researcher recognized for influential contributions to neuroscience, regenerative medicine, spinal cord injury repair, and advanced biomedical technologies. Affiliated with Zhejiang University, Dr. Wang has established a distinguished scientific reputation through innovative studies integrating neural regeneration, biomaterials, gene delivery, and artificial intelligence-based therapeutic design. Their scholarly achievements include 2,855 citations, an h-index of 23, and an
i10-index of 27, reflecting sustained academic impact and international recognition. Dr. Wang’s publications in prestigious journals such as Nature, Cell, and Neuron demonstrate excellence in translational neuroscience and clinical innovation. Through collaborations with renowned global scientists and institutions, the researcher has contributed significantly to advancing functional recovery therapies and neural circuit restoration. Their interdisciplinary expertise continues to influence emerging biomedical strategies aimed at improving neurological healthcare and regenerative treatment methodologies worldwide.

Professional Profile

Education

Dr. Xuhua Wang possesses a strong interdisciplinary academic foundation in neuroscience, biomedical engineering, regenerative medicine, and molecular therapeutics. Their educational development reflects extensive specialization in neural regeneration, fluorescence bioimaging, drug delivery systems, and advanced translational biomedical research. Through academic training and continuous scientific engagement, Dr. Wang cultivated expertise in corticospinal circuitry, neurobiology, nanotechnology-assisted therapeutics, and biomaterials engineering. Association with Zhejiang University further strengthened their research-oriented academic background and exposure to high-level scientific innovation. The combination of theoretical knowledge and laboratory-based experience has enabled Dr. Wang to pursue groundbreaking investigations addressing spinal cord injury recovery and emerging therapeutic technologies in neuroscience.

Professional Experience

Dr. Xuhua Wang has accumulated extensive research experience in neuroscience, regenerative medicine, and biomedical innovation through collaborations with internationally recognized institutions and scientists. Their professional journey includes contributions to spinal cord injury repair, neural pathway reconstruction, advanced hydrogel development, and targeted therapeutic delivery systems. Collaborative research associations with Boston Children’s Hospital and other leading biomedical centers have enhanced their scientific exposure and interdisciplinary expertise. Dr. Wang has actively participated in high-impact experimental studies involving neural regeneration, AI-assisted biomedical applications, and translational medicine. Their professional experience demonstrates strong leadership in conducting innovative research with significant clinical and scientific relevance.

Research Interest

Dr. Xuhua Wang’s research interests focus primarily on spinal cord injury repair, stroke rehabilitation, neural regeneration, biomaterials engineering, and targeted drug and gene delivery systems. Their investigations explore corticospinal tract regeneration, extracellular vesicle therapies, hydrogel-based neural repair technologies, and advanced fluorescence bioimaging techniques. Additionally, Dr. Wang demonstrates growing interest in integrating artificial intelligence for AAV capsid engineering and precision therapeutic design. The interdisciplinary nature of their research combines neuroscience, nanomedicine, molecular biology, and biomedical engineering to develop innovative treatment approaches for neurological disorders. Their scientific interests continue to contribute toward improving functional recovery and regenerative healthcare strategies worldwide.

Award and Honor

Dr. Xuhua Wang has earned significant academic recognition through a highly influential publication record, exceptional citation performance, and impactful scientific contributions in neuroscience and regenerative medicine. With 2,855 total citations, 1,594 citations since 2021, an h-index of 23, and an i10-index of 27, Dr. Wang demonstrates sustained international scholarly influence. Publications in prestigious journals including Nature, Cell, and Nature Communications reflect the quality and significance of their research achievements. Their scientific accomplishments and collaborations with globally recognized researchers highlight professional excellence, innovation, and outstanding contributions to translational neuroscience and biomedical advancement.

Conclusion

Dr. Xuhua Wang has demonstrated exceptional scientific excellence through impactful research in neuroscience, regenerative medicine, and biomedical engineering. Their influential publications, strong citation metrics, and innovative interdisciplinary contributions highlight significant global academic impact. Dr. Wang continues to advance translational healthcare research with remarkable dedication, innovation, and scientific leadership.

Publications Top Noted

Title: Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury
Authors: K Zukor, S Belin, C Wang, N Keelan, X Wang, Z He
Year: 2013
Citation: 346

Title: Touch and tactile neuropathic pain sensitivity are set by corticospinal projections
Authors: Y Liu, A Latremoliere, X Li, Z Zhang, M Chen, X Wang, C Fang, J Zhu, et al.
Year: 2018
Citation: 288

Title: Deconstruction of corticospinal circuits for goal-directed motor skills
Authors: X Wang, Y Liu, X Li, Z Zhang, H Yang, Y Zhang, PR Williams, et al.
Year: 2017
Citation: 245

Title: Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3
Authors: D Jin, Y Liu, F Sun, X Wang, X Liu, Z He
Year: 2015
Citation: 231

Title: A sensitized IGF1 treatment restores corticospinal axon-dependent functions
Authors: Y Liu, X Wang, W Li, Q Zhang, Y Li, Z Zhang, J Zhu, B Chen, PR Williams, et al.
Year: 2017
Citation: 225

 

Lina Posada Calderon | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Dr. Lina Posada Calderon | Medicine | Research Excellence Award

Resident | New York Presbyterian | United States

Dr. Lina Posada Calderon is an accomplished biomedical researcher at Weill Cornell Medicine, New York, specializing in translational and molecular cancer research. Her work focuses on the clinical and molecular characterization of cancers, precision oncology, biomarker discovery, and genetic drivers of tumor progression, with particular emphasis on KRAS-mutated malignancies. She has strong expertise in molecular biology, cancer genomics, clinical data analysis, interdisciplinary research, and high-impact scientific publishing. Her research bridges laboratory discoveries with patient-centered clinical outcomes. Dr. Posada Calderon has published 12 Scopus-indexed documents, receiving 61 citations, and holds an h-index of 5, reflecting her growing scholarly impact and emerging leadership in precision cancer research.

 

Citation Metrics (Scopus)

61
45
30
15
0

Citations

61

Documents

12

h-index

5

Citations

Documents

h-index

View Scopus Profile
 View Google Scholar

Featured Publications

 

Aleksandra Błachnio | Medicine | Research Excellence Award

Published on by Scientific World Research Awards

Prof. Dr. Aleksandra Błachnio | Medicine | Research Excellence Award

Professor | Kazimierz Wielki University | Poland

Prof. Dr. Aleksandra Błachnio is a highly respected scholar in psychology, with a prolific publication record and substantial impact within gerontology, well-being, and social psychology. Her work includes 554 citations, numerous documents (books and articles), and reflects deep commitment to topics such as aging, quality of life in late adulthood, volunteerism among seniors, well-being, life satisfaction across the lifespan, tele-geriatrics, and cross-cultural analysis of psychological health. Her research interests span gerontology and aging psychology, quality-of-life and life-course studies, volunteer activity and social support in old age, psychological adjustment in later life, and mentalization and positive orientation in elderly patients. Among her core research skills are psychometric assessment, longitudinal and cross-sectional survey design, quality-of-life evaluation, social and health psychology methodology, and interdisciplinary analysis of aging and societal change. Her publications such as studies on “health in old age and patient approaches to telemedicine,” “volunteer activity in late adulthood,” and “subjective perception of life-course in old age and youth” showcase her dedication to improving elderly well-being and social inclusion. Her honors include academic recognition as a habilitated doctor in social sciences (psychology), and wide recognition among peers for her contributions to gerontological and social-psychological research. In conclusion, Aleksandra Błachnio stands out as a leading scholar whose enduring research enriches understanding of aging, social participation, and mental health — offering valuable insights for policymakers, healthcare providers, and communities working to enhance quality of life across generations.

Profiles: Scopus | Google Scholar | ResearchGate

Featured Publications

Ziolkowski, A., Blachnio, A., & Pachalska, M. (2015). An evaluation of life satisfaction and health–quality of life of senior citizens. Annals of Agricultural and Environmental Medicine, 22(1). Citations: 47

Litwic-Kaminska, K., Błachnio, A., Kapsa, I., Brzeziński, Ł., Kopowski, J., & others. (2023). Resilience, positivity and social support as perceived stress predictors among university students. International Journal of Environmental Research and Public Health, 20(19), 6892. Citations: 41

Błachnio, A. (2012). Starość non profit. In Wolontariat na Uniwersytetach. Citations: 37

Błachnio, A. (2012). Starość non profit: Wolontariat na Uniwersytetach Trzeciego Wieku w Polsce i na świecie. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 37

Błachnio, A. (2019). Potencjał osób w starości: Poczucie jakości życia w procesie starzenia się. Wydawnictwo Uniwersytetu Kazimierza Wielkiego. Citations: 31

Aniket Gade | Biology | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Aniket Gade | Biology | Best Researcher Award

Associate Professor | Institute of Chemical Technology | India

Dr. Aniket Krishnarao Gade, affiliated with the Institute of Chemical Technology, Mumbai, India, is a prominent researcher in nanotechnology, green chemistry, and sustainable agriculture. He has earned recognition for his extensive contributions to eco-friendly synthesis of metallic and metal-oxide nanoparticles using plant extracts and microbial systems, advancing applications in environmental remediation, crop protection, and biomedical fields. Dr. Gade’s educational background includes a strong foundation in chemical technology and nanoscience, enabling him to integrate interdisciplinary approaches in his research. Professionally, he has developed multifunctional nanomaterials such as Ag-doped ZnO and iron oxide nanoparticles for photocatalytic degradation of environmental pollutants, antimicrobial and antifungal activity, and anticancer therapies, while also exploring innovative solutions in sustainable agriculture through carbon nanodots and pycnidia-forming fungi to enhance crop yield, fertilizer efficiency, and pest management with minimal ecological impact. His research interests encompass nanomaterial synthesis, theranostic nanomedicine, environmental nanotechnology, and agricultural nanobiotechnology, reflecting a commitment to solving real-world challenges through sustainable science. Dr. Gade possesses advanced research skills in nanoparticle fabrication, characterization techniques, biosensor development, and interdisciplinary experimental design, demonstrating a balance of fundamental and applied expertise. Throughout his career, he has received multiple awards and honors recognizing his scientific innovation and impact in nanotechnology and green chemistry. With a prolific record of 122 documents indexed in Scopus, over 15,234 citations, and an h-index of 43, his work has influenced a broad spectrum of scientific studies and applications. In conclusion, Dr. Gade’s career exemplifies a harmonious blend of research excellence, innovation, and societal relevance, making him a leading figure in sustainable nanotechnology and its applications in agriculture, environment, and human health.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Sah, P. M., Gite, S. G., Naik, H. S., Sonawane, R., Nadrowska, J., Golińska, P., Raut, R. W., & Gade, A. K. (2025). Ag-doped ZnO nanoparticles: A versatile multifunctional nanomaterial for anticancer, antibacterial, and recyclable photocatalyst. IEEE Transactions on NanoBioscience.

  2. Rai, M., Shende, S. S., Gade, A. K., Prokisch, J., & Avila-Quezada, G. D. (2025). Carbon nanodots for crop protection and fertilizer use in agriculture. BioNanoScience.

  3. Deshmukh, F., Kiran, K., Pawar, S. V., Nawani, N., Golińska, P., Gade, A., Ingle, P., & Gaikwad, S. C. (2025). Efficient photocatalytic degradation of azo dyes using Achyranthes aspera-mediated magnetic iron oxide nanoparticles: A green synthesis approach. Sustainable Chemistry for the Environment.

  4. Raut, R. W., Naik, H. S., Sah, P. M., Golińska, P., & Gade, A. (2025). A comparative analysis of optical biosensors for rapid detection of SARS‐CoV‐2 and influenza. Biotechnology and Bioengineering.

  5. Shende, S. S., Gade, A. K., Minkina, T. M., Ingle, P. U., Rajput, V. D., Sushkova, S. N., Mandzhieva, S. S., Rai, M., & Wong, M. H. (2024). Exploring sustainable management by using green nano-silver to combat three post-harvest pathogenic fungi in crops. Discover Nano.

 

Shinichiro Sawa | Medicine | Best Researcher Award

Published on by Scientific World Research Awards

Dr. Shinichiro Sawa | Medicine | Best Researcher Award

Professor | Kyushu University | Japan 

Dr. Shinichiro Sawa is a highly accomplished Japanese immunologist and medical researcher renowned for his pioneering work in immune regulation, autoimmunity, and inflammation. He currently serves as a Professor at the Institute of Bioregulation, Kyushu University, Japan, where he leads innovative studies in molecular and cellular immunology. Dr. Sawa began his academic journey at Osaka University, earning his Medical Degree (M.D.) in 2000 and subsequently his Ph.D. in Medicine in 2006 from the same institution, where he developed a strong foundation in biomedical sciences and experimental medicine. His professional trajectory includes significant academic roles as Assistant Professor at the University of Tokyo (2011–2016) and Associate Professor at Hokkaido University’s Institute for Genetic Medicine (2016–2018) before joining Kyushu University in 2019. Dr. Sawa’s research interests center on understanding how immune cells, such as γδ T cells, fibroblasts, and plasma cells, interact with tissue environments to regulate immune tolerance, autoimmunity, and inflammatory diseases. His studies, published in prestigious journals such as Nature Immunology, Journal of Clinical Investigation, and Journal of Investigative Dermatology, have shed light on how fibroblasts contribute to central immune tolerance and how plasma cells promote osteoclastogenesis in autoimmune arthritis. His research skills encompass cellular immunology, molecular signaling analysis, animal modeling of immune diseases, flow cytometry, and translational immunopathology, demonstrating both depth and precision in experimental design and interpretation. Recognized for his scientific contributions, Dr. Sawa has received numerous academic honors and research recognitions throughout his career, reflecting his influence in the global immunology community. In conclusion, Dr. Shinichiro Sawa stands as a leading figure in immunological research, bridging basic science and clinical application to advance our understanding of immune homeostasis and to pave the way for novel therapeutic strategies against autoimmune and inflammatory disorders.

Profiles: Scopus | ORCID

Featured Publications

  1. Nonaka, D., Yoshida, S., Nakano, K., Li, X., Okamura, T., Umemoto, E., Yamada, T., Watanabe, M., Jinno, S., Ito, M., Tsuda, M., Noguchi, N., Jiang, X.-J., Sumiya, E., & Sawa, S. (2025). Fibroblast-derived CSF1 maintains colonization of gut mucosal macrophage to resist bacterial infection. Mucosal Immunology.

  2. Onji, M., Sigl, V., Lendl, T., Novatchkova, M., Ullate-Agote, A., Andersson-Rolf, A., Kozieradzki, I., Koglgruber, R., Pai, T.-P., Lichtscheidl, D., Nayak, K., Zilbauer, M., Carranza García, N.-A., Sievers, L., Falk-Paulsen, M., Cronin, S. J. F., Hagelkruys, A., Sawa, S., Osborne, L. C., Rosenstiel, P., Pasparakis, M., Ruland, J., Takayanagi, H., Clevers, H., Koo, B.-H., & Penninger, J. M. (2025). RANK drives structured intestinal epithelial expansion during pregnancy. Nature, 637(8044), 156–166.

  3. Nitta, T., Tsutsumi, M., Nitta, S., Muro, R., Suzuki, E. C., Nakano, K., Tomofuji, Y., Sawa, S., Okamura, T., Penninger, J. M., & Takayanagi, H. (2020). Fibroblasts as a source of self-antigens for central immune tolerance. Nature Immunology, 21(10), 1172–1180.

  4. Nagashima, K., Sawa, S., Nitta, T., Tsutsumi, M., Okamura, T., Penninger, J. M., Nakashima, T., & Takayanagi, H. (2017). Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nature Immunology, 18(6), 675–682.

  5. Onder, L., Mörbe, U., Pikor, N., Novkovic, M., Cheng, H.-W., Hehlgans, T., Pfeffer, K., Becher, B., Waisman, A., Rülicke, T., Gommerman, J., Müller, C., Sawa, S., Scandella, E., & Ludewig, B. (2017). Lymphatic endothelial cells control initiation of lymph node organogenesis. Immunity, 47(1), 80–92.